Immunomodulation by thalidomide and thalidomide analogues (original) (raw)
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha
Laura G. Corral
Journal of immunology (Baltimore, Md. : 1950), 1999
View PDFchevron_right
Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α
Gilla Kaplan
The Journal of Immunology, 1999
View PDFchevron_right
Discovering a new analogue of thalidomide which may be used as a potent modulator of TNF-α production
Gema Dominguez
European Journal of Medicinal Chemistry, 2009
View PDFchevron_right
TNF{alpha} That Are Potent Inhibitors of Classes of Thalidomide Analogues T Cell Activation by Two Distinct Differential Cytokine Modulation and
Gilla Kaplan
View PDFchevron_right
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
Gilla Kaplan
Journal of Experimental Medicine, 1991
View PDFchevron_right
Selection of novel analogs of thalidomide with enhanced tumor necrosis factor α inhibitory activity
Laura G. Corral
Molecular Medicine
View PDFchevron_right
Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production
Gilla Kaplan
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
Inhibitors of TNF-Thalidomide Analogues That Are Potent Activation by Two Distinct Classes of Differential Cytokine Modulation and T Cell
Laura G. Corral
1999
View PDFchevron_right
Enantioselective inhibition of TNF‐α release by thalidomide and thalidomide‐analogues
Kai Zwingenberger
Chirality, 1996
View PDFchevron_right
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
Gilla Kaplan
Journal of Experimental Medicine, 1993
View PDFchevron_right
Thalidomide analogues: Tumor necrosis factor-alpha inhibitors and their evaluation as anti-inflammatory agents
Juan Casal
View PDFchevron_right
Thalidomide Suppressed IL-1β While Enhancing TNF-α and IL-10, When Cells in Whole Blood were Stimulated with Lipopolysaccharide
felipe sandoval
Immunopharmacology and Immunotoxicology, 2008
View PDFchevron_right
Enantioselective inhibition of TNF? release by thalidomide and thalidomide-analogues
Kai Zwingenberger
Chirality, 1996
View PDFchevron_right
5′-Substituted Thalidomide Analogs as Modulators of TNF
Kai Zwingenberger
Archiv Der Pharmazie, 1998
View PDFchevron_right
Thalidomide analogs and PDE4 inhibition
Laura G. Corral
Bioorganic & Medicinal Chemistry Letters, 1998
View PDFchevron_right
Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs
Faribourz Payvandi
Journal of Pharmacology and Experimental Therapeutics, 2003
View PDFchevron_right
Pharmacological Properties of Thalidomide and its Analogues
Reinaldo Compagnone, Michael Mijares, Juan Sanctis
Recent Patents on Inflammation & Allergy Drug Discovery, 2010
View PDFchevron_right
Thalidomide exerts its inhibitory action on tumor necrosis factor by enhancing mRNA degradation
Andre Moreira
View PDFchevron_right
Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-α production via down-regulation of MyD88 expression
Shafiqul Islam
Innate immunity, 2009
View PDFchevron_right
Recent Developments of Thalidomide Derivatives Possessing Anti-Inflammatory Activity
Hulya Akgun
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2010
View PDFchevron_right
Mono- and Dihydroxylated Metabolites of Thalidomide: Synthesis and TNF-.ALPHA. Production-Inhibitory Activity
Rishav Raj
Chemical and Pharmaceutical Bulletin, 2006
View PDFchevron_right
Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset
Gilla Kaplan
Journal of Experimental Medicine, 1998
View PDFchevron_right
A Single Oral Dose of Thalidomide Enhances the Capacity of Lymphocytes to Secrete Gamma Interferon in Healthy Humans
Peter Speelman
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat
Víctor Pérez-Alvarez
Biochemical Pharmacology, 2004
View PDFchevron_right
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases
Nigel Greig
Acta neurobiologiae experimentalis, 2004
View PDFchevron_right
Thalidomide in immunosuppressors and anti-TNF unresponsive Crohn's disease patients: efficacy and side effects
Laura Cantoro
Journal of Crohn s and Colitis
View PDFchevron_right
Thalidomide and Its Analogs as Anticancer Agents
ChunTa Lab
View PDFchevron_right
High Anti-Inflammatory Activity and Low Toxicity of Thalidomide Analogs
Henrique Couto Teixeira
Medicinal Chemistry, 2015
View PDFchevron_right
Immunological consequences of thalidomide treatment in Sjogren's syndrome
Sharon Wahl
Annals of the Rheumatic Diseases, 2006
View PDFchevron_right
Mucosal Healing With Thalidomide in Refractory Crohn’s Disease Patients Intolerant of Anti-TNF-α Drugs
Laura Cantoro, M. Scribano
Journal of Clinical Gastroenterology, 2014
View PDFchevron_right
Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease
jose tavares
Gut, 2002
View PDFchevron_right
Thalidomide Analogs from Diamines: Synthesis and Evaluation as Inhibitors of TNF-α Production
Henrique C Teixeira
CHEMICAL & PHARMACEUTICAL BULLETIN, 2007
View PDFchevron_right